Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2011
09/21/2011CN102188526A External traditional Chinese medicine composition for treating hyperosteogeny and preparation method thereof
09/21/2011CN102188517A Traditional Chinese medicine for treating hyperosteogeny
09/21/2011CN102188512A Hyperosteogeny plaster
09/21/2011CN102188509A Formulation and preparation method of externally used paste for thunder-fire moxa roll
09/21/2011CN102188508A Chinese medicine composition for treating knee osteoarthritis and preparation method thereof
09/21/2011CN102188496A Chinese medicine for treating ankylosing spondylitis and preparation method thereof
09/21/2011CN102188491A Formula of acupuncture tool for thunder fire needle and manufacturing method
09/21/2011CN102188484A Formula and manufacturing method of medicinal pad for thunder-fire moxibustion
09/21/2011CN102188465A Preparation method of hedera plant extractives and purposes thereof
09/21/2011CN102188464A Coumarin and phenylchromone extract from angelica polymorpha maxim and preparation method and use thereof
09/21/2011CN102188456A Plant extract plaster and preparation method thereof
09/21/2011CN102188452A Formula of strong bone capsule
09/21/2011CN101912510B Traditional Chinese medicine composition for promoting fracture healing at intermediate stage and preparation method thereof
09/21/2011CN101804190B Tongbi cream for relieving rigidity of muscles and promoting blood circulation and preparation method thereof
09/21/2011CN101700389B Traditional Chinese medicine composite for curing rheumatism and rheumatoid diseases
09/21/2011CN101700325B Medicine for treating sciatica caused by protrusion of lubar intervertebral disc
09/21/2011CN101690728B Composition for treating osteoarthritis
09/21/2011CN101653536B Traditional Chinese medicine paste for curing diseases of bones and joints and preparation method thereof
09/21/2011CN101628025B Pharmaceutical composition containing deer bone extractive and melon seed extract
09/21/2011CN101612213B Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion
09/21/2011CN101474390B Medicinal bath powder for scapulohumeral periarthritis
09/21/2011CN101468104B Chinese medicinal compound preparation for treating osteoporosis and method for preparing the same
09/21/2011CN101332288B Traditional Chinese medicine knee-cap and making method thereof
09/21/2011CN101199691B Soaking medicament for treating soft tissue contusion ulcer
09/21/2011CN101195010B Powder medicament for treating acute soft tissue injury
09/21/2011CN101129597B Orally taken traditional Chinese medicine for treating rheumatoid arthritis
09/21/2011CN101049157B Functional health food for preventing osteoporosis
09/20/2011US8022221 Aurora kinase modulators and method of use
09/20/2011US8022176 FAS peptide mimetics and uses thereof
09/20/2011US8022105 Prevention of neutrophil recruitment
09/20/2011US8022058 Agents for preventing and treating disorders involving modulation of the RyR receptors
09/20/2011US8022041 Prodrug of an ICE inhibitor
09/20/2011US8021876 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
09/20/2011US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells
09/20/2011US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities
09/20/2011CA2560523C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
09/20/2011CA2525470C External patch containing estrogen and/or progestogen
09/20/2011CA2516233C 2-propylidene-19-nor-vitamin d compounds
09/20/2011CA2478253C Composition for hard tissue augmentation
09/20/2011CA2473686C Novel cytokine zcytor17 ligand
09/20/2011CA2462903C Beta-lactamyl vasopressin v1a antagonists
09/20/2011CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
09/20/2011CA2458210C Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators
09/20/2011CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
09/20/2011CA2453817C Organophosphorus compounds for the activation of gamma/delta t-cells
09/20/2011CA2439415C Cathepsin cysteine protease inhibitors
09/20/2011CA2411726C Use of ingenanes in treating a pkc-related condition or disorder
09/20/2011CA2376485C Recombinant anti-cd40 antibody and uses thereof
09/20/2011CA2183542C Methods and compositions for stimulating bone cells
09/20/2011CA2115828C Calcium receptor active molecules
09/19/2011CA2696811A1 Glucosamin pro-drugs
09/15/2011WO2011113065A2 Pegylated polyplexes for polynucleotide delivery
09/15/2011WO2011112995A1 Imidazopyridines syk inhibitors
09/15/2011WO2011112875A2 Foamable formulation
09/15/2011WO2011112685A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1)
09/15/2011WO2011112588A2 Compositions and methods for treating inflammatory disorders
09/15/2011WO2011111714A1 Novel ep4 agonist
09/15/2011WO2011111143A1 Medicament for rheumatoid arthritis
09/15/2011WO2011110575A1 Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
09/15/2011WO2011053653A3 Prevotella histicola preparations and the treatment of autoimmune conditions
09/15/2011WO2010132038A3 A formulation and method for relieving or preventing symptoms associated with uric acid crystals
09/15/2011US20110224286 MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY
09/15/2011US20110224283 Antisense modulation of nuclear hormone receptors
09/15/2011US20110224276 optical isomer of phenylpropionic acid and its medicinal use
09/15/2011US20110224267 Selective androgen receptor modulators
09/15/2011US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
09/15/2011US20110224261 Crystalline form of 4-(5--4-methyl-4h-1,2,4-triazol-3-yl)pyridine
09/15/2011US20110224259 Novel inhibitors
09/15/2011US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
09/15/2011US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof
09/15/2011US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases
09/15/2011US20110224194 Staurosporine Derivatives as Inhibitors of FLT3 Receptor Tyrosine Kinase Activity
09/15/2011US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors
09/15/2011US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
09/15/2011US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
09/15/2011US20110224185 Compounds and compositions as modulators of gpr119 activity
09/15/2011US20110224183 16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity
09/15/2011US20110224173 C2-C5-Alkyl-Imidazole-Bisphosphonates
09/15/2011US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended)
09/15/2011US20110224138 Methods for treating pain induced by injuries and diseases of an articular joint
09/15/2011US20110223621 Combinations for the treatment of immunoinflammatory disorders
09/15/2011US20110223253 Physically stabilized biodegradable osteochondral implant and methods for its manufacture and implantation
09/15/2011US20110223248 Methods and compositions for treating lactose intolerance
09/15/2011US20110223221 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention
09/15/2011US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same
09/15/2011US20110223209 Oxygen delivering scaffold for tissue engineering
09/15/2011US20110223203 Nanocluster compositions and methods
09/15/2011US20110223155 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
09/15/2011US20110223133 Therapeutic agent for hematopoietic tumors
09/15/2011US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
09/15/2011US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof
09/15/2011CA2828086A1 Foamable formulation
09/15/2011CA2792769A1 Imidazopyridines syk inhibitors
09/15/2011CA2792403A1 Novel ep4 agonist
09/14/2011EP2365004A2 Membrane associated tumor endothelium markers
09/14/2011EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof
09/14/2011EP2364975A1 Novel amide derivative and use thereof as medicine
09/14/2011EP2364731A2 Methods of administering anti-TNFalpha antibodies
09/14/2011EP2364719A1 Prevention and treatment of amyloidogenic diseases
09/14/2011EP2364316A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d¨pyrimidin-4-yl]-quinolin-3 -ylamine compounds useful as FAAH modulators and uses thereof